Preimplantation Genetic Testing (PGT) involves analyzing, selecting, and transferring embryos with the correct number of chromosomes. This advanced screening improves implantation rates and reduces pregnancy losses by identifying the healthiest embryos before transfer. Women who carry chromosomal disorders, are over 35, or have experienced previous miscarriages are ideal candidates for PGT.

By selecting embryos with the proper chromosomal makeup, PGT helps prevent conditions such as aneuploidy and Down syndrome. Aneuploidy, a condition where an embryo has too many or too few chromosomes, accounts for over 60% of spontaneous miscarriages and is the most common reason for IVF failure. PGT enables the identification of the most viable embryos for transfer, reducing the need to transfer multiple embryos and minimizing the risk of multiple pregnancies.